- Report
- June 2023
- 100 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- April 2023
- 275 Pages
Global
From €3793EUR$3,990USD£3,187GBP
- Report
- May 2024
- 134 Pages
From €6178EUR$6,499USD£5,190GBP
- Report
- October 2021
- 100 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- June 2022
- 118 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- August 2020
- 112 Pages
Global
From €4040EUR$4,250USD£3,394GBP
- Report
- December 2023
- 62 Pages
Global
From €9502EUR$9,995USD£7,982GBP
- Report
- February 2024
- 25 Pages
Global
€16304EUR$17,150USD£13,697GBP
- Report
- January 2021
- 38 Pages
Global
€1253EUR$1,318USD£1,053GBP
- Report
- October 2024
- 103 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- January 2024
- 126 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- May 2023
- 112 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- March 2025
- 50 Pages
Global
From €2519EUR$2,650USD£2,116GBP
- Report
- March 2025
- 50 Pages
Global
From €2519EUR$2,650USD£2,116GBP
Colchicine is a medication used to treat and prevent gout and other inflammatory conditions. It is a member of the cardiovascular drug class, which includes drugs used to treat and prevent heart and blood vessel diseases. Colchicine works by reducing inflammation and swelling, and is often used to treat acute gout attacks. It is also used to treat familial Mediterranean fever, pericarditis, and Behcet's disease.
Colchicine is available in both oral and injectable forms, and is typically taken once or twice a day. Common side effects include nausea, vomiting, and diarrhea. Serious side effects include liver damage, kidney failure, and bone marrow suppression.
The colchicine market is highly competitive, with many generic and branded products available. Companies in the market include Mylan, Teva Pharmaceuticals, Sandoz, and Sun Pharmaceuticals. Show Less Read more
